Idexx Laboratories

Idexx Laboratories (IDXX) is a publicly traded company in the Health Care sector, specifically within the Health Care Equipment industry. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

The company reports trailing twelve-month revenue of $1.14B and net income of $278.45M.

Key metrics include a return on equity of 17.9%, a debt-to-equity ratio of 1.18.

Investors tracking IDXX can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.